Offstream
news

Mexican health regulator COFEPRIS approves the emergency use of Pfizer's anti-COVID-19 oral drug Paxlovid.
2022-01-14

Mexican health regulator COFEPRIS grants emergency use authorization for Merck & Co.'s anti-COVID-19 drug Molnupiravir for the treatment of severe disease.
2022-01-7

Mexico reports 16,244 new cases of COVID-19 in the past 24 hours, the highest daily total in the country since January.
2021-07-22

Mexico receives the first shipment of 200,000 doses of Sputnik V vaccine.
2021-02-22

Hungary approves the use of the Sputnik V vaccine in the country.
2021-02-7

Turkmenistan registers the Sputnik V vaccine despite having no confirmed cases in the country, according to the Russian Direct Investment Fund. It becomes the first country in Central Asia to approve a Russian-made vaccine.
2021-01-18

Argentina receives their second batch of Russia's Sputnik V vaccine.
2021-01-16

Mexico reports a record 13,734 new cases in the past 24 hours, bringing the nationwide total of cases to 1,493,569.
2021-01-7

Peru surpasses one million cases of COVID-19, becoming the fifth Latin American country to surpass the milestone after Brazil, Argentina, Colombia, and Mexico.
2020-12-22

Mexican Foreign Minister Marcelo Ebrard announces the country has signed agreements with AstraZeneca for 77.4 million, COVAX for 51.57 million, CanSino Biologics for 35 million, and Pfizer for 34.4 million vaccine doses, respectively. The vaccines by Pfizer, AstraZeneca, and the COVAX plan require two doses, whereas the CanSino product requires one dose.
2020-10-13